Galli named pathology
chair, Loveless professor
BY JOYCE THOMAS
Stephen J. Galli, MD,
professor of pathology and microbiology and immunology,
has been named chair of the Department of Pathology and
the first Mary Hewitt Loveless, MD, Professor in the
School of Medicine, effective March 1. Originally a
research fund, the gift from the Mary Hewitt Loveless
Estate was recently designated for the establishment of
the new professorship at the direction of medical school
Dean Eugene A. Bauer, MD.
Galli, who joined Stanford
this year, replaces Klaus Bensch, MD, as pathology chair.
Bensch stepped down from the department leadership post,
after serving as chair since 1984 including one year as
acting chair. He came to Stanford as a professor in 1968
after several years on the faculty at Yale University
School of Medicine.
"Klaus Bensch has
been an outstanding leader in pathology. I am grateful
for his many years of service to the department and the
school. We are fortunate to have such a talented new
leader to step into the post. Stephen Galli will provide
a strong vision for the department," said Dean
Bauer.
Before coming to Stanford,
Galli, a 1973 Harvard Medical School graduate, had been
on the Harvard faculty since 1979, serving as professor
since 1993. His postdoctoral training included a
residency and several research fellowships at
Massachusetts General Hospital, Boston, and at Harvard.
He also served as director of the pathology research
laboratories at Beth Israel Hospital and as director of
the division of experimental pathology at the Beth Israel
Deaconess Medical Center.
Galli's many professional
affiliations include membership in the American Society
for Clinical Investigation and election to the
Association of American Physicians. He is a fellow of the
Molecular Medicine Society and a recently elected
councilor of the American Society for Investigative
Pathology. Galli's major research interests include mast
cell and basophil development and function and allergy,
immunology and inflammation, particularly allergic
inflammation.
Loveless, who was one of
only two women in the Stanford School of Medicine class
of 1925, gained recognition early in her career as an
established medical scientist and research physician.
While on the faculty at Cornell University Medical
School, she began research that culminated in the first
design for immunotherapy against life-threatening
anaphylaxis from insect stings. She retired from Cornell
in 1964 but continued her commitment to research and to
patients until her death in 1991 at the age of 92. She
directed her estate to carry on that commitment by
providing research funding to Stanford. SR
|
